TruAlt Bioenergy Limited — PPTs, 22-05-2026: Investor Presentation

Here's a summary of the investor presentation for TruAlt Bioenergy, focusing on key highlights for retail investors:

**Business Performance:**

Full-year total income saw a dip of 8.64% to ₹1772.94 Cr. Standalone EBITDA also declined by 5.35% to ₹337.71 Cr. This was primarily impacted by reduced ethanol offtake from OMCs and delays in a significant court-ordered allocation. The company is working to resolve these issues to improve future performance.

**Growth Drivers or Strategy:**

TruAlt Bioenergy is strategically evolving from a seasonal, ethanol-focused business to an integrated bioenergy platform. Key focus areas include:

* **Ethanol:** Expanding to a near year-round, multi-feedstock operation for greater resilience.

* **Compressed Biogas (CBG):** Progressing with JV partnerships for developing multiple CBG plants to tap into the growing green gas market.

* **Sustainable Aviation Fuel (SAF):** Advancing plans for a SAF facility, positioning for a significant future growth opportunity.

**Recent Developments:**

The company has completed strategic share purchase transactions for its CBG joint ventures with Sumitomo Corporation and GAIL (India) Limited. Construction for several CBG plants is underway.

**Key Financial Metrics (if available):**

For the year ended March 31, 2026:

* Total Income (Standalone): ₹1772.94 Cr.

* EBITDA (Standalone): ₹337.71 Cr.

* PAT (Standalone): ₹80.03 Cr.

**Management Commentary / Outlook:**

Management emphasizes the long-term strategic importance of biofuels amid global energy volatility. They are optimistic about increased ethanol demand due to higher blending targets and policy support. The company aims to improve capacity utilization in its ethanol segment and sees significant potential in its CBG and SAF expansion plans as key drivers for future growth.